Maze Therapeutics (MAZE) Tax Rate (2024)
Maze Therapeutics' (MAZE) quarterly Tax Rate came in at 0.67% in Q4 2024, down 44.1% quarter-over-quarter from 1.2% in Q3 2024.
Maze Therapeutics (MAZE) Tax Rate (2024) Analysis & Trends
Maze Therapeutics has disclosed Tax Rate across 1 years of filings, most recently posting 0.67% for Q4 2024.
- Tax Rate for Q4 2024 came in at 0.67%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.15% (changed N/A YoY), and the FY2024 annual result was 2.25%, changed N/A from the prior year.
- Tax Rate came in at 0.67% for Q4 2024 at Maze Therapeutics, down from 1.2% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 1.23% in Q2 2024 to a low of 0.67% in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 5.61% |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Maze Therapeutics | 1.31 Bn | 1.31 Bn | 18.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.67% |
| Dec 31, 2024 | 0.67% |
| Sep 30, 2024 | 1.20% |
| Sep 30, 2024 | 1.20% |
| Jun 30, 2024 | 1.23% |
| Jun 30, 2024 | 1.23% |